Seroprevalence of SARS-COV-2 in a rural population of Ecuador

  • Danny Larco Hospital Saludesa, Laboratory of Microbiology and Molecular Biology, Santo Domingo, Ecuador.
Keywords: SARS COV-2, antibodies, seroprevalence, vaccine, symptoms, ELISA

Abstract

The present study seeks to determine the total IgG, IgM and IgA antibodies against SARS COV-2 in a population of the Ecuadorian highlands. The sample universe is comprised of 318 adults, 187 men and 131 women. The percentage of positivity was 42.5%. Prior to sampling, a survey was conducted on the symptoms, diagnostic tests and vaccination of SARS COV-2. Correlation of positive results was found for our test with participants who presented symptoms of SARS COV-2 infection confirmed by PCR (89.7%), also correlation between people who claimed not to have had symptoms of SARS COV-2 infection with test results negative (75.6%). There was a small number of results classified as false negatives (2.8%). In addition, the results of people who claimed to have never had symptoms of SARS COV-2 infection and obtained positive results in the antibody test (14.7%) that would be considered as asymptomatic carriers.

Downloads

Download data is not yet available.

References

1. Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, Adriano A, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Dittrich S, Emperador D, Hooft L, Leeflang MMG, Van den Bruel A. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database of Systematic Reviews 2020, Issue 6. Art. No.: CD013652. Doi: 10.1002/14651858.CD013652
2. Rostami A, Sepidarkish M, Leeflanf M, et al. (2020). SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analisis. Clin Micro and Infection. Published Oct 23, 2020. DOI: https://doi.org/10.1016/j.cmi.2020.10.020
3. Huang C, Wang Y, Li X, et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497-506
4. Sidiq Z, Hanif M, Dwivedi K, et al. (2020). Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc. Dec; 67(4): S163-S166. Doi: 10.1016/j.ijtb.2020.07.034
5. Acurio D, Gómez A, Orellana D, Vega B, Charry R, et al. (2020) Estudio de seroepidemiología de la infección por SARS COV-2 en el cantón Cuenca. https://ucuenca.edu.ec.
6. Álava N, Ávila M, Castro J. et al. (2021) Seroprevalencia de la COVID-19, factores de riesgo y protocolos de bioseguridad en el personal de salud de la ciudad de Jipijapa provincia de Manabí, Ecuador. Doi: 10.23857/pc.v6i7.2825
Published
2021-07-30
How to Cite
1.
Larco D. Seroprevalence of SARS-COV-2 in a rural population of Ecuador. PFR [Internet]. 2021Jul.30 [cited 2024Nov.21];6(2). Available from: https://practicafamiliarrural.org/index.php/pfr/article/view/207
Section
Artículos Originales